Epigenetics in etiopathology of hyperprolactinemia
Amanpreet Kaur Kalsi , Ashutosh Halder , Manish Jain , Jai Bhagwan Sharma
Exploration of Endocrine and Metabolic Diseases ›› 2024, Vol. 1 ›› Issue (2) : 39 -55.
Aim: Epigenetic alterations have been reported in patients with pituitary tumors and those on antipsychotic drugs, which are also responsible for hyperprolactinemia. This suggests a possible role of epigenetics in the etiopathology of hyperprolactinemia. Methods: The study recruited 83 hyperprolactinemia cases with prolactin > 100 ng/mL and 65 controls. Global DNA methylation status was studied by MethylFlash Methylated DNA Quantification Kit and genome-wide methylation analysis (GWMA) by Infinium Methylation EPIC BeadChip 850K array. Results: Hyperprolactinemia cases showed significant global DNA hypermethylation compared to controls. Around 66.67% of hypomethylated and 12.9% of hypermethylated cases were on antipsychotics. Gene enrichment analysis of 5-cytosine-phosphate-guanine-3 (CpG) site-associated genes demonstrated significantly enriched major histocompatibility complex (MHC)-related protein classes and cellular components. Conclusions: The study suggested the role of epigenetics in the etiopathology of hyperprolactinemia.
Epigenetics / hyperprolactinemia / prolactin / etiopathology / pituitary adenoma / antipsychotics / global DNA methylation / genome-wide methylation analysis
| [1] |
Grayson DR. Special issue introduction: role of epigenetic gene regulation in brain function. Genes (Basel). 2017; 8: 181. |
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004; 429: 457-63. |
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
Davis JR. Prolactin and reproductive medicine. Curr Opin Obstet Gynecol. 2004; 16: 331-7. |
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014; 511: 421-7. |
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
Madden DR. The three-dimensional structure of peptide-MHC complexes. Annu Rev Immunol. 1995; 13: 587-622. |
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
Bainbridge DR. Evolution of mammalian pregnancy in the presence of the maternal immune system. Rev Reprod. 2000; 5: 67-74. |
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
|
| [69] |
|
| [70] |
|
| [71] |
|
| [72] |
|
| [73] |
|
| [74] |
|
| [75] |
Díaz L, |
| [76] |
|
/
| 〈 |
|
〉 |